Optimal ACTH Cell Dose Identified for Regenerative Therapy in Post-Surgery Pituitary Deficiency

The pituitary gland plays a vital role in hormone regulation, and its damage, often due to surgery for tumors, can lead to hypopituitarism—a deficiency in one or more pituitary hormones. One critical consequence is ACTH deficiency, which impairs the adrenal glands' ability to produce essential hormones like cortisol, leading to adrenal insufficiency. Current treatments involve lifelong hormone replacement, but regenerative medicine seeks to restore natural function. This study addresses the crucial knowledge gap of establishing an optimal cell dosage for ACTH-producing cell transplantation to effectively treat post-operative hypopituitarism.

The group receiving 5x10^5 ACTH-producing cells demonstrated significantly superior outcomes compared to other doses and controls. Plasma ACTH levels in this optimal group increased by a remarkable 3.2-fold compared to untreated controls (p<0.001), reaching 88% of healthy baseline levels by week 8. Concurrently, corticosterone levels (a key adrenal hormone) were 55% higher than the 1x10^5 cell group and 30% higher than the 1x10^6 cell group (p<0.01 for both comparisons), indicating robust adrenal stimulation. Adrenal gland weight in the 5x10^5 group was 18% greater than controls, suggesting structural and functional restoration. > The optimal dosage of ACTH-producing cells at 5x10^5 cells significantly restored adrenal function, reducing the need for exogenous corticosteroid support by 65% compared to untreated controls (p<0.001). Furthermore, this group exhibited reduced inflammatory markers in the adrenal glands by 35% and improved stress response profiles.